- Home
- KRO vs ATRC Comparison
KRO vs ATRC Comparison
Compare KRO & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- ATRC
- Stock Information
- Founded
- KRO 1916
- ATRC 2000
- Country
- KRO United States
- ATRC United States
- Employees
- KRO N/A
- ATRC N/A
- Industry
- KRO Major Chemicals
- ATRC Medical/Dental Instruments
- Sector
- KRO Industrials
- ATRC Health Care
- Exchange
- KRO Nasdaq
- ATRC Nasdaq
- Market Cap
- KRO 1.1B
- ATRC 1.1B
- IPO Year
- KRO N/A
- ATRC 2005
- Fundamental
- Price
- KRO $9.57
- ATRC $39.84
- Analyst Decision
- KRO Hold
- ATRC Strong Buy
- Analyst Count
- KRO 3
- ATRC 9
- Target Price
- KRO $12.00
- ATRC $43.00
- AVG Volume (30 Days)
- KRO 172.2K
- ATRC 618.4K
- Earning Date
- KRO 03-05-2025
- ATRC 02-12-2025
- Dividend Yield
- KRO 2.09%
- ATRC N/A
- EPS Growth
- KRO N/A
- ATRC N/A
- EPS
- KRO 0.82
- ATRC N/A
- Revenue
- KRO $1,864,100,000.00
- ATRC $447,573,000.00
- Revenue This Year
- KRO $25.77
- ATRC $18.02
- Revenue Next Year
- KRO $6.54
- ATRC $12.93
- P/E Ratio
- KRO $11.72
- ATRC N/A
- Revenue Growth
- KRO 15.87
- ATRC 17.56
- 52 Week Low
- KRO $8.26
- ATRC $18.94
- 52 Week High
- KRO $14.50
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- KRO 42.13
- ATRC 61.66
- Support Level
- KRO $9.58
- ATRC $39.71
- Resistance Level
- KRO $9.92
- ATRC $43.11
- Average True Range (ATR)
- KRO 0.26
- ATRC 1.86
- MACD
- KRO 0.05
- ATRC 0.15
- Stochastic Oscillator
- KRO 34.31
- ATRC 63.10
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in a variety of products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second-largest product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.